Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy

Kishore, 2000, C1q: structure, function, and receptors, Immunopharmacol., 49, 159, 10.1016/S0162-3109(00)80301-X

Yurasov, 2005, Defective B cell tolerance checkpoints in systemic lupus erythematosus, J Exp Med, 201, 703, 10.1084/jem.20042251

Van Montfoort, 2007, A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes, J Immunol, 178, 7581, 10.4049/jimmunol.178.12.7581

Waggoner, 2005, gC1q receptor ligation selectively down-regulated human IL-2 production through activation of the phosphoinositide 3-kinase pathway, J Immunol, 175, 4706, 10.4049/jimmunol.175.7.4706

Kittlesen, 2000, Interaction between the complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation, J Clin Invest, 106, 1239, 10.1172/JCI10323

Eisen-Vandervelde, 2004, Hepatitis C virus core selectively suppresses interleukin 12-synthesis in human macrophages by interfering with AP-1 activation, J Biol Chem, 279, 43479, 10.1074/jbc.M407640200

Ghebrehiwet, 1998, Structure and Function of gC1q-R: a multiligand binding cellular protein, Immunobiol, 199, 225, 10.1016/S0171-2985(98)80029-6

van Leeuwen, 2001, Retargeting of the mitochondrial protein p32/gC1QR to a cytoplasmic compartment and the cell surface, J Cell Sci, 114, 2115, 10.1242/jcs.114.11.2115

Peterson, 1997, The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: Subcellular distribution and immunochemical characterization, Clin Immunol Immunopathol, 84, 17, 10.1006/clin.1997.4374

Peerschke, 2015, Soluble gC1qR in blood and body fluids: examination in a pancreatic cancer patient cohort, Int J Cancer Res Molec Mech, 1, 17, 10.16966/ijcrmm.110

Soltys, 2000, Localization of p32 protein (gC1q-R) in mitochondria and at specific extramitochondrial locations in normal tissues, Histochem Cell Biol, 114, 245, 10.1007/s004180000191

Saha, 2018, Multi-functional, multicompartmental hyaluronan-binding protein 1 (HABP1/p32/gC1qR): implication in cancer progression and metastasis, Oncotarget, 9, 10784, 10.18632/oncotarget.24082

Rubinstein, 2004, Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells, Int J Cancer, 110, 741, 10.1002/ijc.20105

Dembitzer, 2012, gC1qR expression in normal and pathologic human tissues: differential expression in tissues of epithelial and mesenchymal origin, J Histochem Cytochem, 60, 467, 10.1369/0022155412440882

Amamoto, 2011, Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy, Cancer Sci, 102, 639, 10.1111/j.1349-7006.2010.01828.x

Chen, 2009, Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer, J Surg Oncol, 100, 382, 10.1002/jso.21329

Yu, 2013, Significance of hyaluronan binding protein (HABP1/P32/gC1qR) expression in advanced serous ovarian cancer patients, Exp Mol Pathol, 94, 210, 10.1016/j.yexmp.2012.06.007

Zhao, 2015, Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer, Tumour Biol, 36, 1299, 10.1007/s13277-014-2761-8

Kamal, 2006, Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with cisplatin induced apoptosis, Apoptosis, 11, 861, 10.1007/s10495-006-5396-4

Lv, 2017, The role of the globular heads of the C1q receptor in paclitaxel-induced human ovarian cancer cells apoptosis by a mitochondria-dependent pathway, Anticancer Drugs, 29, 107, 10.1097/CAD.0000000000000567

Ling, 2018, C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism, Science, 360, 558, 10.1126/science.aao4555

Ghebrehiwet, 1990, Interaction of C1q with its receptor on cultured cell lines induces an anti-proliferative response, Clin Immunol Immunopathol, 54, 148, 10.1016/0090-1229(90)90014-H

Yao, 2004, Direct binding of hepatitis C virus core to gC1qR on CD4(+) and CD8(+) T cells leads to impaired activation of Lck and Akt, J Virol, 78, 6409, 10.1128/JVI.78.12.6409-6419.2004

Kandov, 2018, C1q and C1q receptors (gC1qR and cC1qR) as potential novel targets for therapy against breast cancer, Curr Trends Immunol, 19, 59

McGee, 2011, The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death, Cell Cycle, 23, 419, 10.4161/cc.10.23.18287

Mossman, 1998, Mechanisms in the pathogenesis of asbestosis and silicosis, Am J Respir Crit Care Med, 157, 1666, 10.1164/ajrccm.157.5.9707141

Adusumilli, 2014, Translational immunotherapeutics: chemoimmunotherapy for malignant pleural mesothelioma, Cancer, 120, 3268, 10.1002/cncr.28883

Krug, 2009, Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma, J Clin Oncol, 27, 3007, 10.1200/JCO.2008.20.3943

Nelson, 2017, Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis, J Clin Oncol, 35, 3354, 10.1200/JCO.2017.73.8401

Vogelzang, 2003, Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma, J Clin Oncol, 21, 2636, 10.1200/JCO.2003.11.136

Ujiie, 2015, The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: a comprehensive analysis reveals prognostic immune markers, Oncoimmunol, 4, e1009285, 10.1080/2162402X.2015.1009285

Batirel, 2017, Extrapeural pneumonectomy (EPP) vs. pleurectomy decorication (P/D), Ann Transl Med, 5, 232, 10.21037/atm.2017.03.82

Eguchi, 2017, Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1, Oncotarget, 8, 77872, 10.18632/oncotarget.20845

2015, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart

Krishnamurti, 2017, Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers, Hum Pathol, 64, 7, 10.1016/j.humpath.2017.01.004

Suzuki, 2011, Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients, Cancer Immunol. Immunother, 60, 1721, 10.1007/s00262-011-1073-8

Ghebrehiwet, 1996, Identification of functional domains on gClQ-R, a cell surface protein that binds to the globular “heads” of C1Q, using monoclonal antibodies and synthetic peptides, Hybridoma, 15, 333, 10.1089/hyb.1996.15.333

Kadota, 2012, A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma, Mod Pathol, 25, 260, 10.1038/modpathol.2011.146

Penault-Llorca, 2009, Ki67 expression and docetaxel efficacy in patients with estrogen receptor–positive breast cancer, J Clin Oncol, 27, 2809, 10.1200/JCO.2008.18.2808

Enomoto, 2016, Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers, Inter J Clin Oncol, 21, 254, 10.1007/s10147-015-0897-1

Yerushalmi, 2010, Ki67 in breast cancer: prognostic and predictive potential, Lancet Oncol, 11, 174, 10.1016/S1470-2045(09)70262-1

Ghanim, 2015, Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study, Brit J Cancer, 112, 783, 10.1038/bjc.2015.9

Chen, 1994, Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation, J Immunol, 153, 1430, 10.4049/jimmunol.153.4.1430

Agostinis, 2017, Complement protein C1q binds to hyaluronic acid in the malignant pleural mesothelioma microenvironment and promotes tumor growth, Front Immunol, 10.3389/fimmu.2017.01559

Cortes-Dericks, 2017, CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives, Respir Res, 18, 58, 10.1186/s12931-017-0546-5

Creaney, 2013, Pleural effusion hyaluronic acid as a prognostic marker in pleural mesothelioma, Lung Cancer., 82, 491, 10.1016/j.lungcan.2013.09.016

Knudson, 1998, The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue, Front Biosci, 3, d604, 10.2741/A305

Ghebrehiwet, 2004, cC1qR (calreticulin) and gC1qR (p33): ubiquitously expressed multiligand binding cellular proteins involved in inflammation and infection, Mol Immunol, 41, 73, 10.1016/S0161-5890(04)00076-8